register

Medical and Science

Former health official appointed to lead new strategy as Research Australia and STA warn of key gaps

Health Industry Hub | November 18, 2024 |

Former deputy secretary of the Department of Health, Rosemary Huxtable AO PSM, has been appointed to spearhead the development of the National Health and Medical Research Strategy.

Federal Health Minister Mark Butler MP emphasised the significance of this effort, stating, “Australia has a proud history of punching above our weight when it comes to new discoveries and better treatments in healthcare. The strategy will ensure we remain at the forefront of global health and medical innovation.

“Under Rosemary’s leadership the strategy will help foster a strong and sustainable research workforce, create an environment that attracts investment, and translate research into practical health outcomes.”

The strategy comes in response to sustained advocacy from Research Australia, which has called for coordinated, sustainable investment in research, stronger ties between research and healthcare, and support for emerging health industries.

The organisation also stressed that “the strategy must include innovation and industry. Just as the Strategic Examination of R&D, currently underway, must include health and medical research. To be truly national, the Strategy must have input from all States and Territory Governments, all portfolios and jurisdictions.”

Science & Technology Australia (STA) has consistently called for government action on strategic frameworks and increased funding for Australian R&D, which sits at despairingly low levels.

Ryan Winn, STA CEO, said “Given the interconnectedness and complexity of Australia’s research funding landscape, it will be vital that this strategy is developed in close conjunction with the Strategic Examination of R&D.

“It will be vital that the development of the Strategy must involve all parts of the research pipeline, including state and territory governments, philanthropy and industry – not just health and medical researchers.”

Health and medical research is one of the five key pillars in the government’s National Science and Research Priorities released in August this year by the Minister for Industry and Science, Ed Husic MP.

Huxtable, who brings extensive experience in government policy, financial management, and strategic leadership, is expected to lead a comprehensive consultation process across the health and medical research sector.

She will commence in the role later this year, with a webinar to be held with the health and medical research sector on 5th December 2024. Huxtable will provide a draft strategy to government by 30 June 2025 and a final strategy by the end of 2025.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Biotechnology

CSL reshapes R&D while bracing for U.S. tariffs

CSL reshapes R&D while bracing for U.S. tariffs

Health Industry Hub | July 11, 2025 |

Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]

More


News & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension

Australia joins Medtronic trial in fight against resistant hypertension

Health Industry Hub | July 11, 2025 |

Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]

More


News & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban

Health Industry Hub | July 11, 2025 |

Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]

More


News & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer

Global pledge shifts visibility and action for patients with advanced breast cancer

Health Industry Hub | July 11, 2025 |

Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]

More


This content is copyright protected. Please subscribe to gain access.